- Associated Press - Wednesday, April 1, 2015

FOREST, Va. (AP) - Teva Pharmaceutical Industries Ltd. will supply the U.S. military with a Virginia-made vaccine to combat the spread of infectious respiratory disease in basic training camps.

Media outlets report the Army announced the $170 million contract Monday between Jerusalem-based Teva and the U.S. Defense Department.

The adenovirus vaccine is manufactured at Teva’s plant in Forest.

Under the five-year contract, the company anticipates the military’s nine basic training camps will need about 250,000 vaccine doses per year.



Click to Read More

Click to Hide